Siemens gets warning letter over blood sample testing device
Siemens Healthcare Diagnostics, part of Siemens (NYSE:SI), has received a warning letter from the U.S. Food and Drug Administration over allegedly changing without following proper protocol the design of an immunoassay device used to test blood and other biological liquids. The letter, addressed to its Tarrytown, New York office dated May 29, said the company […]